The page is the record's research on the issuer — no analyst, no rating, no view. # ArriVent BioPharma, Inc. (NASDAQ: AVBP) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is ArriVent BioPharma, Inc., listed on NASDAQ under ticker AVBP. Its ISIN is US04272N1028 and its LEI is not on the record. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Its listing status is listed, not halted. ## The disclosure read The record holds 42 filings across 22 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 8 days, and the latest filing is dated 2026-11-05, 3 days before the record date, of type regulatory_filing. The NASDAQ median cadence gap is 6.0 days, the NASDAQ median filings count is 52, and the NASDAQ median latency is 5.0 days. The sector median cadence gap is 6.0 days, the sector median filings count is 63.0, and the sector median latency is 4.0 days. By type, the record holds 13 regulatory filings, 11 directors' dealings, 7 corporate news, 7 results, 3 AGM or EGM, and 1 prospectus. ## Auditor The auditor of record is not on the record, and its location is not on the record. The record carries no dei:AuditorName tag on the latest annual report cover. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record. The segment move is not on the record. The halt flag shows listed, not halted. ## Orderability The orderability outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001868279.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/AVBP (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/AVBP (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/AVBP · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp